KILITCH DRUGS (INDIA) LTD. - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
28 Oct 2020
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 27, 2020 for Bhavin Mehta
Source:
BSE India